| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation.
|
J Am Coll Cardiol
|
2004
|
5.67
|
|
2
|
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.
|
N Engl J Med
|
2007
|
5.37
|
|
3
|
Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization And Urgent Intervention Triage Strategy (ACUITY) substudy.
|
Circulation
|
2010
|
3.95
|
|
4
|
Vascular complications associated with arteriotomy closure devices in patients undergoing percutaneous coronary procedures: a meta-analysis.
|
J Am Coll Cardiol
|
2004
|
3.67
|
|
5
|
Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial.
|
Lancet
|
2011
|
3.00
|
|
6
|
A risk score to predict bleeding in patients with acute coronary syndromes.
|
J Am Coll Cardiol
|
2010
|
2.62
|
|
7
|
Prognostic impact of staged versus "one-time" multivessel percutaneous intervention in acute myocardial infarction: analysis from the HORIZONS-AMI (harmonizing outcomes with revascularization and stents in acute myocardial infarction) trial.
|
J Am Coll Cardiol
|
2011
|
2.49
|
|
8
|
Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial.
|
Circulation
|
2009
|
2.47
|
|
9
|
A volumetric intravascular ultrasound comparison of early drug-eluting stent thrombosis versus restenosis.
|
JACC Cardiovasc Interv
|
2009
|
2.30
|
|
10
|
Impact of the presence and extent of incomplete angiographic revascularization after percutaneous coronary intervention in acute coronary syndromes: the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.
|
Circulation
|
2012
|
2.26
|
|
11
|
Outcomes of optimal or "stent-like"balloon angioplasty in acutemyocardial infarction: the CADILLAC trial.
|
J Am Coll Cardiol
|
2003
|
2.18
|
|
12
|
Differential clinical responses to everolimus-eluting and Paclitaxel-eluting coronary stents in patients with and without diabetes mellitus.
|
Circulation
|
2011
|
2.17
|
|
13
|
Relationship between myocardial reperfusion, infarct size, and mortality: the INFUSE-AMI (Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction) trial.
|
JACC Cardiovasc Interv
|
2013
|
2.08
|
|
14
|
Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial.
|
JAMA
|
2007
|
1.84
|
|
15
|
Impact of gender on the incidence and outcome of contrast-induced nephropathy after percutaneous coronary intervention.
|
J Invasive Cardiol
|
2003
|
1.77
|
|
16
|
Comparison of everolimus- and paclitaxel-eluting stents in patients with acute and stable coronary syndromes: pooled results from the SPIRIT (A Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (A Trial of Everolimus-Eluting Stents and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice) Trials.
|
JACC Cardiovasc Interv
|
2011
|
1.66
|
|
17
|
In vivo virtual histology intravascular ultrasound correlates of risk factors for sudden coronary death in men: results from the prospective, multi-centre virtual histology intravascular ultrasound registry.
|
Eur Heart J
|
2008
|
1.65
|
|
18
|
Outcomes of patients with coronary artery perforation complicating percutaneous coronary intervention and correlations with the type of adjunctive antithrombotic therapy: pooled analysis from REPLACE-2, ACUITY, and HORIZONS-AMI trials.
|
J Interv Cardiol
|
2009
|
1.64
|
|
19
|
Short- and long-term results after multivessel stenting in diabetic patients.
|
J Am Coll Cardiol
|
2004
|
1.57
|
|
20
|
Impact of gender and age on in vivo virtual histology-intravascular ultrasound imaging plaque characterization (from the global Virtual Histology Intravascular Ultrasound [VH-IVUS] registry).
|
Am J Cardiol
|
2009
|
1.56
|
|
21
|
Prognostic impact of blood transfusion after primary angioplasty for acute myocardial infarction: analysis from the CADILLAC (Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications) Trial.
|
JACC Cardiovasc Interv
|
2009
|
1.54
|
|
22
|
Impact of lesion length and vessel size on clinical outcomes after percutaneous coronary intervention with everolimus- versus paclitaxel-eluting stents pooled analysis from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) and COMPARE (Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice) Randomized Trials.
|
JACC Cardiovasc Interv
|
2011
|
1.53
|
|
23
|
Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction.
|
Circ Cardiovasc Interv
|
2009
|
1.51
|
|
24
|
Development and validation of a stent thrombosis risk score in patients with acute coronary syndromes.
|
JACC Cardiovasc Interv
|
2012
|
1.50
|
|
25
|
Gender and the extent of coronary atherosclerosis, plaque composition, and clinical outcomes in acute coronary syndromes.
|
JACC Cardiovasc Imaging
|
2012
|
1.48
|
|
26
|
Impact of stenting and abciximab in patients with diabetes mellitus undergoing primary angioplasty in acute myocardial infarction (the CADILLAC trial).
|
Am J Cardiol
|
2005
|
1.47
|
|
27
|
An evaluation of fluoroscopy time and correlation with outcomes after percutaneous coronary intervention.
|
J Invasive Cardiol
|
2007
|
1.46
|
|
28
|
Outcomes in diabetic patients undergoing primary percutaneous coronary intervention for acute anterior myocardial infarction: results from the INFUSE-AMI study.
|
Catheter Cardiovasc Interv
|
2013
|
1.45
|
|
29
|
Coronary reperfusion and clinical outcomes after thrombus aspiration during primary percutaneous coronary intervention: findings from the HORIZONS-AMI trial.
|
Catheter Cardiovasc Interv
|
2013
|
1.44
|
|
30
|
Relation between white blood cell count and final infarct size in patients with ST-segment elevation acute myocardial infarction undergoing primary percutaneous coronary intervention (from the INFUSE AMI trial).
|
Am J Cardiol
|
2013
|
1.42
|
|
31
|
Adverse event rates following primary PCI for STEMI at US and non-US hospitals: three-year analysis from the HORIZONS-AMI trial.
|
EuroIntervention
|
2013
|
1.41
|
|
32
|
The impact of the coronary collateral circulation on outcomes in patients with acute coronary syndromes: results from the ACUITY trial.
|
Heart
|
2013
|
1.41
|
|
33
|
Impact of platelet glycoprotein IIb/IIIa receptor inhibitors on outcomes of diabetic patients undergoing percutaneous coronary interventions using sirolimus-eluting stents.
|
Catheter Cardiovasc Interv
|
2008
|
1.39
|
|
34
|
Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction.
|
Circulation
|
2003
|
1.38
|
|
35
|
Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach.
|
Eur Heart J
|
2007
|
1.37
|
|
36
|
Plaque composition and clinical outcomes in acute coronary syndrome patients with metabolic syndrome or diabetes.
|
JACC Cardiovasc Imaging
|
2012
|
1.24
|
|
37
|
Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial.
|
J Am Coll Cardiol
|
2011
|
1.23
|
|
38
|
What to tell dementia caregivers--the rule of threes.
|
Int J Geriatr Psychiatry
|
2003
|
1.20
|
|
39
|
Gender differences in outcomes after primary angioplasty versus primary stenting with and without abciximab for acute myocardial infarction: results of the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
|
Circulation
|
2005
|
1.19
|
|
40
|
Drug-eluting stents in the treatment of intermediate lesions: pooled analysis from four randomized trials.
|
J Am Coll Cardiol
|
2006
|
1.17
|
|
41
|
Gastrointestinal bleeding in patients with acute coronary syndromes: incidence, predictors, and clinical implications: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
|
J Am Coll Cardiol
|
2009
|
1.16
|
|
42
|
Predictors of infarct size after primary coronary angioplasty in acute myocardial infarction from pooled analysis from four contemporary trials.
|
Am J Cardiol
|
2007
|
1.14
|
|
43
|
Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes.
|
JACC Cardiovasc Imaging
|
2012
|
1.14
|
|
44
|
Paclitaxel-eluting coronary stents in patients with diabetes mellitus: pooled analysis from 5 randomized trials.
|
J Am Coll Cardiol
|
2008
|
1.11
|
|
45
|
Magnitude and impact of treatment delays on weeknights and weekends in patients undergoing primary angioplasty for acute myocardial infarction (the cadillac trial).
|
Am J Cardiol
|
2004
|
1.09
|
|
46
|
Longitudinal distribution of plaque burden and necrotic core-rich plaques in nonculprit lesions of patients presenting with acute coronary syndromes.
|
JACC Cardiovasc Imaging
|
2012
|
1.08
|
|
47
|
5-year clinical outcomes after sirolimus-eluting stent implantation insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents.
|
J Am Coll Cardiol
|
2009
|
1.07
|
|
48
|
Relationship between palpography and virtual histology in patients with acute coronary syndromes.
|
JACC Cardiovasc Imaging
|
2012
|
1.04
|
|
49
|
Impact of anemia on clinical outcomes of patients with ST-segment elevation myocardial infarction in relation to gender and adjunctive antithrombotic therapy (from the HORIZONS-AMI trial).
|
Am J Cardiol
|
2010
|
1.04
|
|
50
|
Incidence and predictors of heart failure following percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI trial.
|
Am Heart J
|
2011
|
1.03
|
|
51
|
Adverse cardiovascular events arising from atherosclerotic lesions with and without angiographic disease progression.
|
JACC Cardiovasc Imaging
|
2012
|
1.02
|
|
52
|
Residual plaque burden in patients with acute coronary syndromes after successful percutaneous coronary intervention.
|
JACC Cardiovasc Imaging
|
2012
|
1.01
|
|
53
|
Prevalence, distribution, predictors, and outcomes of patients with calcified nodules in native coronary arteries: a 3-vessel intravascular ultrasound analysis from Providing Regional Observations to Study Predictors of Events in the Coronary Tree (PROSPECT).
|
Circulation
|
2012
|
1.00
|
|
54
|
Angiographic patterns of drug-eluting stent restenosis and one-year outcomes after treatment with repeated percutaneous coronary intervention.
|
Am J Cardiol
|
2008
|
0.96
|
|
55
|
Intraprocedural thrombotic events during percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes are associated with adverse outcomes: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.
|
J Am Coll Cardiol
|
2012
|
0.95
|
|
56
|
Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions.
|
Am J Cardiol
|
2004
|
0.95
|
|
57
|
Impact of the severity of coronary artery calcification on clinical events in patients undergoing coronary artery bypass grafting (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial).
|
Am J Cardiol
|
2013
|
0.95
|
|
58
|
Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the HORIZONS-AMI trial.
|
Int J Cardiol
|
2012
|
0.95
|
|
59
|
Benefits and risks of abciximab use in primary angioplasty for acute myocardial infarction: the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial.
|
Circulation
|
2003
|
0.92
|
|
60
|
Impact of major bleeding and blood transfusions after cardiac surgery: analysis from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial.
|
Am Heart J
|
2012
|
0.91
|
|
61
|
Incidence and clinical consequences of acquired thrombocytopenia after antithrombotic therapies in patients with acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) trial.
|
Am Heart J
|
2011
|
0.90
|
|
62
|
Stent thrombosis: insights on outcomes, predictors and impact of dual antiplatelet therapy interruption from the SPIRIT II, SPIRIT III, SPIRIT IV and COMPARE trials.
|
EuroIntervention
|
2012
|
0.90
|
|
63
|
Infarct size and mortality in patients with proximal versus mid left anterior descending artery occlusion: the Intracoronary Abciximab and Aspiration Thrombectomy in Patients With Large Anterior Myocardial Infarction (INFUSE-AMI) trial.
|
Am Heart J
|
2013
|
0.88
|
|
64
|
Impact of leukocyte count on mortality and bleeding in patients with myocardial infarction undergoing primary percutaneous coronary interventions: analysis from the Harmonizing Outcome with Revascularization and Stent in Acute Myocardial Infarction trial.
|
Circulation
|
2011
|
0.88
|
|
65
|
Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries.
|
J Am Coll Cardiol
|
2006
|
0.87
|
|
66
|
The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale.
|
Am Heart J
|
2008
|
0.87
|
|
67
|
Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
|
JACC Cardiovasc Interv
|
2009
|
0.86
|
|
68
|
Quantitative angiographic methods for appropriate end-point analysis, edge-effect evaluation, and prediction of recurrent restenosis after coronary brachytherapy with gamma irradiation.
|
J Am Coll Cardiol
|
2002
|
0.86
|
|
69
|
Gender-specific outcomes after sirolimus-eluting stent implantation.
|
J Am Coll Cardiol
|
2007
|
0.86
|
|
70
|
Predictive value of C-reactive protein on 30-day and 1-year mortality in acute coronary syndromes: an analysis from the ACUITY trial.
|
J Thromb Thrombolysis
|
2011
|
0.85
|
|
71
|
Short- and long-term outcomes after stent-assisted percutaneous treatment of saphenous vein grafts in the drug-eluting stent era.
|
Am J Cardiol
|
2007
|
0.85
|
|
72
|
The axial distribution of lesion-site atherosclerotic plaque components: an in vivo volumetric intravascular ultrasound radio-frequency analysis of lumen stenosis, necrotic core and vessel remodeling.
|
Ultrasound Med Biol
|
2008
|
0.85
|
|
73
|
Impact of diabetes mellitus on the safety and effectiveness of bivalirudin in patients with acute myocardial infarction undergoing primary angioplasty: analysis from the HORIZONS-AMI (Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction) trial.
|
JACC Cardiovasc Interv
|
2011
|
0.84
|
|
74
|
Comparison of Bivalirudin versus Bivalirudin plus glycoprotein IIb/IIIa inhibitor versus heparin plus glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes having percutaneous intervention for narrowed saphenous vein aorto-coronary grafts (the ACUITY trial investigators).
|
Am J Cardiol
|
2010
|
0.84
|
|
75
|
Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial).
|
Am J Cardiol
|
2005
|
0.84
|
|
76
|
Comparison of clinical and angiographic prognostic risk scores in patients with acute coronary syndromes: Analysis from the Acute Catheterization and Urgent Intervention Triage StrategY (ACUITY) trial.
|
Am Heart J
|
2012
|
0.83
|
|
77
|
High platelet reactivity on clopidogrel therapy correlates with increased coronary atherosclerosis and calcification: a volumetric intravascular ultrasound study.
|
JACC Cardiovasc Imaging
|
2012
|
0.83
|
|
78
|
Clinical and angiographic predictors of short- and long-term ischemic events in acute coronary syndromes: results from the Acute Catheterization and Urgent Intervention Triage strategY (ACUITY) trial.
|
Circ Cardiovasc Interv
|
2010
|
0.82
|
|
79
|
Predictors of suboptimal TIMI flow after primary angioplasty for acute myocardial infarction: results from the HORIZONS-AMI trial.
|
EuroIntervention
|
2013
|
0.82
|
|
80
|
Plaque composition by intravascular ultrasound and distal embolization after percutaneous coronary intervention.
|
JACC Cardiovasc Imaging
|
2012
|
0.81
|
|
81
|
Impact of symptomatic peripheral arterial disease on 1-year mortality in patients undergoing percutaneous coronary interventions.
|
J Endovasc Ther
|
2004
|
0.81
|
|
82
|
Postprocedure creatine kinase-MB elevation and baseline left ventricular dysfunction predict one-year mortality after percutaneous coronary intervention.
|
Am J Cardiol
|
2002
|
0.81
|
|
83
|
Safety and efficacy of high- versus low-dose aspirin after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial.
|
JACC Cardiovasc Interv
|
2012
|
0.81
|
|
84
|
Long-term prognosis of patients presenting with ST-segment elevation myocardial infarction with no significant coronary artery disease (from the HORIZONS-AMI trial).
|
Am J Cardiol
|
2012
|
0.80
|
|
85
|
Relation between late patency of the infarct-related artery, left ventricular function, and clinical outcomes after primary percutaneous intervention for acute myocardial infarction (CADILLAC trial).
|
Am J Cardiol
|
2004
|
0.80
|
|
86
|
Complementary prognostic utility of myocardial blush grade and ST-segment resolution after primary percutaneous coronary intervention: analysis from the HORIZONS-AMI trial.
|
Am Heart J
|
2013
|
0.80
|
|
87
|
Impact of smoking on outcomes of patients with ST-segment elevation myocardial infarction (from the HORIZONS-AMI Trial).
|
Am J Cardiol
|
2011
|
0.80
|
|
88
|
Age- and gender-related changes in plaque composition in patients with acute coronary syndrome: the PROSPECT study.
|
EuroIntervention
|
2012
|
0.80
|
|
89
|
Are adverse events following an invasive strategy in patients with non-ST-segment elevation acute coronary syndromes more frequent at US sites versus non-US sites? Analysis from the ACUITY trial.
|
Catheter Cardiovasc Interv
|
2013
|
0.79
|
|
90
|
Prognostic significance of elevated baseline troponin in patients with acute coronary syndromes and chronic kidney disease treated with different antithrombotic regimens: a substudy from the ACUITY trial.
|
Circ Cardiovasc Interv
|
2012
|
0.79
|
|
91
|
Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial).
|
Am J Cardiol
|
2003
|
0.79
|
|
92
|
Coronary artery calcification is inversely related to body morphology in patients with significant coronary artery disease: a three-dimensional intravascular ultrasound study.
|
Eur Heart J Cardiovasc Imaging
|
2013
|
0.79
|
|
93
|
Impact of scheduled angiographic follow-up in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.
|
J Interv Cardiol
|
2013
|
0.79
|
|
94
|
Comparison of the angiographic outcomes after beta versus gamma vascular brachytherapy for treatment of in-stent restenosis.
|
Am J Cardiol
|
2003
|
0.78
|
|
95
|
Prognostic significance of postprocedural sustained ventricular tachycardia or fibrillation in patients undergoing primary percutaneous coronary intervention (from the HORIZONS-AMI Trial).
|
Am J Cardiol
|
2011
|
0.78
|
|
96
|
Impact of bifurcation target lesion on angiographic, electrocardiographic, and clinical outcomes of patients undergoing primary percutaneous coronary intervention (from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction [HORIZONS-AMI] trial).
|
EuroIntervention
|
2013
|
0.78
|
|
97
|
Minimally invasive coronary artery bypass grafting versus stenting for patients with proximal left anterior descending coronary artery disease.
|
Am J Cardiol
|
2004
|
0.78
|
|
98
|
Predictors of death or myocardial infarction, ischaemic-driven revascularisation, and major adverse cardiovascular events following everolimus-eluting or paclitaxel-eluting stent deployment: pooled analysis from the SPIRIT II, III, IV and COMPARE trials.
|
EuroIntervention
|
2011
|
0.78
|
|
99
|
Benefits of optimising coronary flow before stenting in primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from INFUSE-AMI.
|
EuroIntervention
|
2014
|
0.77
|
|
100
|
An intravascular ultrasound appraisal of atherosclerotic plaque distribution in diseased coronary arteries.
|
Am Heart J
|
2012
|
0.77
|
|
101
|
Intravascular ultrasound comparison of left main coronary artery disease between white and Asian patients.
|
Am J Cardiol
|
2013
|
0.77
|
|
102
|
Operator versus core laboratory assessment of angiographic reperfusion markers in patients undergoing primary percutaneous coronary intervention for ST-segment-elevation myocardial infarction.
|
Circ Cardiovasc Interv
|
2012
|
0.77
|
|
103
|
Intravascular brachytherapy for native coronary ostial in-stent restenotic lesions.
|
J Am Coll Cardiol
|
2003
|
0.77
|
|
104
|
Impact of baseline thrombocytopenia on the early and late outcomes after ST-elevation myocardial infarction treated with primary angioplasty: analysis from the Harmonizing Outcomes with Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) trial.
|
Am Heart J
|
2011
|
0.77
|
|
105
|
Usefulness of atrial fibrillation as a marker of outcome after percutaneous coronary intervention.
|
Am J Cardiol
|
2003
|
0.77
|
|
106
|
A new score for risk stratification of patients with acute coronary syndromes undergoing percutaneous coronary intervention: the ACUITY-PCI (Acute Catheterization and Urgent Intervention Triage Strategy-Percutaneous Coronary Intervention) risk score.
|
JACC Cardiovasc Interv
|
2012
|
0.77
|
|
107
|
Comparison of the effects of pretreatment with tirofiban, clopidogrel or both on the inhibition of platelet aggregation and activation in patients with acute coronary syndromes.
|
J Thromb Thrombolysis
|
2007
|
0.76
|
|
108
|
Response to letters regarding article, “Predictors of outcomes in medically treated patients with acute coronary syndromes after angiographic triage: an Acute Catheterization and Urgent Intervention Triage Strategy (ACUITY) substudy”.
|
Circulation
|
2011
|
0.75
|
|
109
|
Gamma radiation for in-stent restenosis: effect of lesion length on angiographic and clinical outcomes.
|
Catheter Cardiovasc Interv
|
2004
|
0.75
|
|
110
|
Impact of thienopyridine administration prior to primary stenting in acute myocardial infarction.
|
J Interv Cardiol
|
2009
|
0.75
|
|
111
|
Does clinical presentation affect outcome among patients with acute coronary syndromes undergoing percutaneous coronary intervention? Insights from the Providing Regional Observations to Study Predictors of Events in the Coronary Tree study.
|
Am Heart J
|
2012
|
0.75
|
|
112
|
Impact of advanced age on the safety and effectiveness of paclitaxel-eluting stent implantation in patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: The HORIZONS-AMI trial.
|
Catheter Cardiovasc Interv
|
2013
|
0.75
|
|
113
|
Prognostic significance of coronary thrombus in patients undergoing percutaneous coronary intervention for acute coronary syndromes: a subanalysis of the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.
|
JACC Cardiovasc Interv
|
2011
|
0.75
|
|
114
|
Implications of the presence and length of "geographic miss" on restenosis and the edge phenomenon in the INHIBIT trial.
|
Am J Cardiol
|
2003
|
0.75
|
|
115
|
How patients and staff view the use of seclusion.
|
Nurs Times
|
2002
|
0.75
|
|
116
|
Implications of pre-procedural TIMI flow in patients with non ST-segment elevation acute coronary syndromes undergoing percutaneous coronary revascularization: insights from the ACUITY trial.
|
Int J Cardiol
|
2012
|
0.75
|
|
117
|
Correlations between epicardial flow, microvascular reperfusion, infarct size and clinical outcomes in patients with anterior versus non-anterior myocardial infarction treated with primary or rescue angioplasty: analysis from the EMERALD trial.
|
EuroIntervention
|
2009
|
0.75
|
|
118
|
Feasibility and efficacy of tandem positioning on angiographic and clinical outcomes in the Intimal Hyperplasia Inhibition with Beta In-Stent Trial.
|
Am J Cardiol
|
2003
|
0.75
|
|
119
|
Comparison of catheterization laboratory initiated abciximab and eptifibatide during percutaneous coronary intervention in acute coronary syndromes (an ACUITY substudy).
|
Am J Cardiol
|
2010
|
0.75
|
|
120
|
Influence of admission and discharge aspirin use on survival after primary coronary angioplasty for acute myocardial infarction.
|
Am J Cardiol
|
2004
|
0.75
|
|
121
|
Implications of myocardial reperfusion on survival in women versus men with acute myocardial infarction undergoing primary coronary intervention.
|
Am J Cardiol
|
2013
|
0.75
|